Press releases
- Press releases
- Browse
Press releases
APR Applied Pharma Research announces a 50mg diclofenac potassium sachet for drinkable solution, developed according to its new patented drug delivery technology useful to improve efficacy and safety of fast acting formulations containing diclofenac More
Nimesulide beyond COX2 symposium at the Annual European Congress of Rheumatology (EULAR 2000), held in Nice, 21-24 June, 2000 More
Nimesulide at the VII World Conference on Clinical Pharmacology and Therapeutics (CPT 2000), held in Florence, 15-20 July 2000 More
The German R&D Company Labtec GmbH and the Swiss R&D Company APR Applied Pharma Research S.A. have recently partnered together for the further development, registration and licensing out of a high tech., top of the art NSAID topical patch for More
Reddy US Therapeutics, Inc. has filed for patent protection covering drug targets and methods that provide a new approach to therapeutics for inflammatory disease More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 40 pages - $500
Dec 2010 - 84 pages - $500
Mar 2011 - 34 pages - $1,000
Nov 2011 - 7 pages - $3,835
Mar 2011 - 16 pages - $250
Jun 2006 - 378 pages - $2,495
Apr 2009 - 450 pages - $3,490
Oct 2010 - 169 pages - $3,500
Oct 2011 - 134 pages - $500
Mar 2011 - 82 pages - $500
Your selection
Browse By
- Industry sector
- Academic/Research
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Non-profit org./Government
- Pharmaceutical
- Research tools
- Service
- Therapeutic target
- Age-related disorders (other)
- Back pain
- Birth defects
- Bone cancer
- Chronic granulomatous disease
- Dupuytren's disease
- Dyskinesia
- Fibrocystic breast disease
- Gout
- Growth disorders
- Hypomobility
- Intermittent claudication
- Leprosy
- Lupus erythematosis
- Muscular
- Musculoskeletal disorder (other)
- Scleroderma
- Sjogren's syndrome
- Skeletal
- Trauma, physical
- Wasting disease
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us